In an attempt to identify the best treatment for pregnant women with cardiac-valve prostheses who are receiving oral anticoagulants, we studied 72 pregnancies prospectively. In 23 pregnancies (Group I), the coumarin derivative acenocoumarol was discontinued and the patients received 5,000 U of subcutaneous heparin every 12 hours from the 6th to the 12th week of gestation, in 12 pregnancies (Group II), heparin was not substituted for the coumarin derivative until after the 7th week, and in 37 pregnancies, detected after the first trimester (Group III), the coumarin derivative was given throughout gestation. In most patients heparin was again substituted for the oral anticoagulant after the 38th week. Three mothers had thrombosis of a tilting-disk mitral prosthesis (two cases were fatal) during heparin treatment. No differences were found in the rates of spontaneous abortion in the three groups. Coumarin embryopathy occurred in 25 percent and 29.6 percent of the pregnancies in Groups II and III, respectively. We conclude that in the second and third trimesters of pregnancy, coumarin derivatives provide effective protection against thromboembolism while causing few fetopathic effects, but that these agents are contraindicated from the 6th to the 12th weeks of gestation. Low-dose heparin does not protect against prosthetic-valve thrombosis, and the possibility that a larger dose might be more effective requires further exploration.
This article has been cited by other articles:
James, A. H.
(2009). Venous Thromboembolism in Pregnancy. Arterioscler. Thromb. Vasc. Bio.
29: 326-331
[Abstract][Full Text]
GIBSON, P. S., POWRIE, R.
(2009). Anticoagulants and pregnancy: When are they safe?. Cleveland Clinic Journal of Medicine
76: 113-127
[Abstract][Full Text]
2006 WRITING COMMITTEE MEMBERS, , Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C. Jr, Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., O'Rourke, R. A., Otto, C. M., Shah, P. M., Shanewise, J. S.
(2008). 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation
118: e523-e661
[Full Text]
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C. Jr, Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., O'Rourke, R. A., Otto, C. M., Shah, P. M., Shanewise, J. S., Nishimura, R. A., Carabello, B. A., Faxon, D. P., Freed, M. D., Lytle, B. W., O'Gara, P. T., O'Rourke, R. A., Shah, P. M.
(2008). 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol
52: e1-e142
[Full Text]
Bates, S. M., Greer, I. A., Pabinger, I., Sofaer, S., Hirsh, J.
(2008). Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest
133: 844S-886S
[Abstract][Full Text]
Al Halees, Z.
(2007). The Choice of Valve Prosthesis: Are the Guidelines for Everyone?. Asian Cardiovasc. Thorac. Ann.
15: 457-458
[Full Text]
Khamooshi, A. J, Kashfi, F., Hoseini, S., Tabatabaei, M. B, Javadpour, H., Noohi, F.
(2007). Anticoagulation for Prosthetic Heart Valves in Pregnancy. Is There an Answer?. Asian Cardiovasc. Thorac. Ann.
15: 493-496
[Abstract][Full Text]
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C. Jr, Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., O'Rourke, R. A., Otto, C. M., Shah, P. M., Shanewise, J. S., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Faxon, D. P., Fuster, V., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Lytle, B. W., Nishimura, R., Page, R. L., Riegel, B.
(2006). ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol
48: e1-e148
[Full Text]
Elkayam, U., Bitar, F.
(2005). Valvular Heart Disease and Pregnancy: Part II: Prosthetic Valves. J Am Coll Cardiol
46: 403-410
[Abstract][Full Text]
Ginsberg, J. S., Chan, W. S., Bates, S. M., Kaatz, S.
(2003). Anticoagulation of Pregnant Women With Mechanical Heart Valves. Arch Intern Med
163: 694-698
[Abstract][Full Text]
Hung, L., Rahimtoola, S. H.
(2003). Prosthetic Heart Valves and Pregnancy. Circulation
107: 1240-1246
[Full Text]
Bates, S. M., Ginsberg, J. S.
(2002). How we manage venous thromboembolism during pregnancy. Blood
100: 3470-3478
[Abstract][Full Text]
Leyh, R. G., Fischer, S., Ruhparwar, A., Haverich, A.
(2002). Anticoagulation for prosthetic heart valves during pregnancy: is low-molecular-weight heparin an alternative?. Eur. J. Cardiothorac. Surg.
21: 577-579
[Abstract][Full Text]
(2001). Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J
22: 1852-1923
Fuster, V., Ryden, L. E., Asinger, R. W., Cannom, D. S., Crijns, H. J., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Levy, S., McNamara, R. L., Prystowsky, E. N., Wann, L. S., Wyse, D. G., Gibbons, R. J., Antman, E. M., Alpert, J. S., Faxon, D. P., Fuster, V., Gregoratos, G., Hiratzka, L. F., Jacobs, A. K., Russell, R. O., Smith, S. C. Jr, Klein, W. W., Alonso-Garcia, A., Blomstrom-Lundqvist, C., De Backer, G., Flather, M., Hradec, J., Oto, A., Parkhomenko, A., Silber, S., Torbicki, A.
(2001). ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol
38: 1266-1266
[Full Text]
van Driel, D., Wesseling, J., Sauer, P. J. J., van der Veer, E., Touwen, B. C. L., Smrkovsky, M.
(2001). In Utero Exposure to Coumarins and Cognition at 8 to 14 Years Old. Pediatrics
107: 123-129
[Abstract][Full Text]
Ginsberg, J. S., Greer, I., Hirsh, J.
(2001). Use of Antithrombotic Agents During Pregnancy. Chest
119
: 122S-131S
[Full Text]
Chan, W. S., Anand, S., Ginsberg, J. S.
(2000). Anticoagulation of Pregnant Women With Mechanical Heart Valves: A Systematic Review of the Literature. Arch Intern Med
160: 191-196
[Abstract][Full Text]
Meschengieser, S S, Fondevila, C G, Santarelli, M T, Lazzari, M A
(1999). Anticoagulation in pregnant women with mechanical heart valve prostheses. Heart
82: 23-26
[Abstract][Full Text]
Vitale, N., De Feo, M., De Santo, L. S., Pollice, A., Tedesco, N., Cotrufo, M.
(1999). Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol
33: 1637-1641
[Abstract][Full Text]
Vongpatanasin, W., Hillis, L. D., Lange, R. A.
(1996). Prosthetic Heart Valves. NEJM
335: 407-416
[Full Text]
Badui, E., Enciso, R.
(1996). Acute Myocardial Infarction During Pregnancy and Puerperium Review. ANGIOLOGY
47: 739-756
[Abstract]
Hirsh, J., Hoak, J.
(1996). Management of Deep Vein Thrombosis and Pulmonary Embolism : A Statement for Healthcare Professionals From the Council on Thrombosis (in Consultation With the Council on Cardiovascular Radiology), American Heart Association. Circulation
93: 2212-2245
[Full Text]
Hastings, G. E., Seery, D. S., Vine, D. L.
(1993). Recent Developments in the Diagnosis, Treatment, and Prevention of Pulmonary Embolism. Arch Fam Med
2: 655-669
[Abstract]
(1989). Cardiogenic Brain Embolism: The Second Report of the Cerebral Embolism Task Force. Arch Neurol
46: 727-743
[Abstract]
Previous
